Fontanarosa Joann

Lopes João F, Moster Marlene R, Wilson Richard P, Altangerel Undraa, Alvim Heryberto S, Tong Melissa G et al.

This study found subconjunctival sodium hyaluronate 2.3% during trabeculectomy did not improve surgical success rates but led to more diffuse blebs, suggesting limited direct clinical benefit for IOP control.

Bayer Atilla, Henderer Jeffrey D, Kwak Terry, Myers Jonathan, Fontanarosa Joann, Spaeth George L

Latanoprost efficacy was moderately linked to higher pre-treatment IOP, but weakly decreased with advancing optic disc damage and age, suggesting less impact in advanced disease.

Henderer Jeffrey D, Wilson Richard P, Moster Marlene R, Myers Jonathan, Schmidt Courtland, Fontanarosa Joann et al.

Cosopt significantly lowered intraocular pressure in patients with IOP over 30 mmHg, suggesting it's an effective initial treatment for severe glaucoma.

Rai Sushma, Moster Marlene R, Kesen Muge, Fontanarosa Joann, Spaeth George L, Steinmann William C et al.

This study found significant disagreement between Proview and Goldmann IOP readings. However, regular Proview use significantly reduced glaucoma patients' anxiety, suggesting potential psychological benefits despite poor IOP accuracy.

Wamsley Sonja, Moster Marlene R, Rai Sushma, Alvim Heryberto S, Fontanarosa Joann

This pilot study of Ex-PRESS implants directly under the conjunctiva for advanced glaucoma found significant IOP reduction, but an unacceptably high rate of complications, including hypotony and choroidal issues.

Seligsohn Audrey, Moster Marlene R, Steinmann William, Fontanarosa Joann